LB Pharmaceuticals Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
28.7M
on 2026-06-30, from 25.3M on 2025-09-30 10-Q ↗
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
None
No at-the-market programme on file in the last 30 months.
Cash
15.9 quarters
$327.8M on 2026-06-30 ÷ $20.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-07-28 | Private placement incl. 0.72M pre-funded | 4,293,073 | not read | $150.0M | 8-K ↗ |
| 2026-02-04 | Private placement incl. 1.42M pre-funded | 4,723,678 | not read | $100.0M | 8-K ↗ |
| 2025-09-10 | Public offering | 19,000,000 | $15.00 | not read | 424B4 ↗ |